Insect biorefinery: it exists, it works
Insect biorefinery. Almost unimaginable, a few years ago. And yet, it is in full development. Its products will come to the market soon. The insect world will show us many surprising applications. The surprising world of insects Every now and then one comes across a subject that is entirely new and surprising. Like insect biorefinery,
Investment in biobased materials and chemicals is on the rise, says Lux Research
The BioBased Materials and Chemicals (BBMC) sector has clearly recovered from the 2008 setback, when many start-ups performed less than expected and many went bankrupt. Investment is on the rise from 2013 onwards, and will come close to $ 1 billion (€ 780 million) in 2014, a 28% increase from 2013. Says Lux Research in
Tina Sejersgård Fanø (Novozymes): we want to remain an innovation-based company
‘As a company, we want to feed the world, save CO2, move to a greener and more biobased economy, improve lives. But we always want to remain innovation-based and bring innovation to the customer. In order to facilitate that, we need partnerships with companies that sell consumer products.’ Says Tina Sejersgård Fanø, Novozymes vice-president Business
The plight of the innovative SME, the case of SeaLife Pharma
‘In twenty years’ time, SeaLife Pharma will not exist anymore,’ says its CEO Alexander Pretsch. In many companies, such a statement would be cause for concern. But Pretsch implies that he expects his company to be successful. I.e. that it will be able to find a big pharmaceutical partner that is willing to invest in
Bionylon
The Italian blog Il Bioeconomista recently announced that the American biotech company Genomatica (San Diego) intends to develop enzymatic industrial pathways for the production of the chemical building blocks hexamethylenediamine, adipic acid and caprolactam. These compounds are drop-ins in the petrochemical industry, and precursors for nylon 6 and nylon 6.6. In this way, the company
Trust is the basis of successful R&D
The problem surfaces everywhere: how to organise successful R&D in a cooperation between research institutes and businesses. Two worlds with very different cultures. Each with their proper rules and their proper criteria for success. Freedom to publish in the world of research versus secrecy until a patent has been awarded in the business world. Whereas
Biobased transition in Europe: how fast?
At the conference where the report ‘Opportunities for the fermentation-based chemical industry’ was published, we also talked to Marcel Wubbolts, DSM’s CTO and president of BIC (the Biobased Industry Consortium). How long could the biobased transition for the chemical industry take, in his opinion? According to Marcel, partnerships of companies and governments are essential. If


















